Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 26.04.2006 KEY FIGURES 2005 2004 Revenue in EUR m 321.3 299.4 EBIT ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 29.03.2006 > Consolidated net income up 15% > EBIT increases by 7% > EUR 1.00 per share dividend proposal > Order backlog 9% above the prior year Dettingen/Erms, March 29, 2006 --- The ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 21.03.2006 The group generated the following results in the 2005 financial year: 2005 2004 Change Turnover TEUR 34,871 25,167 +38.6% Profit TEUR ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 13.03.2006 Thanks to the continuation of the favorable business environment for rolled steel and tubes, Salzgitter AG concluded the 2005 financial year posting new record sales and profit levels. Consolidated external sales grew by 20 % to EUR 7.15 ...
Ludwigshafen, Germany (ots) - * BASF Intends To Offer US$37.00 Per Share For a Total of US$4.9 Billion * Acquisition Would Make BASF a Leading Provider in the Global Catalyst Business BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN), the world's leading chemical company, has made an all-cash proposal to acquire all outstanding shares of common stock of Engelhard ...
Dublin, Ireland, November 21 (ots/PRNewswire) - - New hope for HIV/AIDS patients: APTIVUS(R) outperforms several commonly prescribed drugs in the protease inhibitor (PI) class DUBLIN, Ireland, November 21 /PRNewswire/ -- - Experts Emphasize Need for Effective Therapy in Response to Increased Prevalence of HIV/AIDS throughout Europe At the 10th European AIDS Clinical Society (EACS) conference, experts ...
Dublin, Ireland, November 21 (ots/PRNewswire) - - Additional Data Provide Further Guidance on Maximizing Treatment Response with APTIVUS(R) New data presented at the 10th European AIDS Conference (EACS) in Dublin demonstrate that through 48 weeks, APTIVUS(R) (tipranavir) provides a convincing and durable benefit, achieving and maintaining a superior treatment response in patients with resistant HIV.(1) ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 13.11.2005 Against the backdrop of ongoing satisfactory development in the rolled steel and tubes businesses, Salzgitter AG has set new sales and profit records for the first nine months of a ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 30.09.2005 "The 2005/2006 financial year got off to a positive start for feratel. Consolidated sales increased from TEUR 2,753.7 in the first quarter of the previous year to TEUR 2,812.1 in the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.08.2005 In the first six months of the financial year 2005, Salzgitter AG achieved an outstanding increase in both sales and profit. Whereas the rolled steel business still benefited from ...
Rio De Janeiro, Brazil and Ingelheim, Germany (ots/PRNewswire) - - New Data Support its Use as Powerful Treatment Against HIV Drug Resistance RIO DE JANEIRO, Brazil and INGELHEIM, Germany, July 28 /PRNewswire/ -- Boehringer Ingelheim announced today that the CHMP (Committee for Medicinal Products for Human Use) in London has issued a positive opinion for tipranavir, a non-peptidic protease inhibitor, to ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.07.2005 curasan AG - specialists in regenerative medicine - today received 510(k) approval by the FDA for Cerasorb® M Dental and Cerasorb® Perio. Cerasorb® is a synthetic bone ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 21.07.2005 "In the 2004/2005 business year, sales totaled EUR 15.4 million (after EUR 15.7 million in the previous year). Operating revenues in the year under report increased from EUR 16.5 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 21.07.2005 Kleinostheim, July 21, 2005 - curasan AG (WKN 549 453) today announced its financial results for the second quarter ended June 30, 2005. In the second quarter, the company generated ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 13.05.2005 Thanks to strong global demand and the generally satisfactory level of prices - achieved in stages since the beginning of last year - for rolled steel products and tubes, the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.05.2005 Kleinostheim, May 12, 2005 - curasan AG (WKN 549 453) today announced its financial results for the first quarter ended March 31, 2005. In the first three months of the 2005 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 10.05.2005 The continued decline in German construction activity accelerated in early 2005. The latest figures published by the Federal Statistical Office for the building construction sector ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 29.04.2005 ~ KEY FIGURES 2004 2003 Revenue in mEUR 299.4 323.0 EBIT in mEUR 13.7 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 17.03.2005 Although incoming orders in the building construction sector, which are an important business indicator for Westag & Getalit AG, declined by another 6.3% in 2004 according to the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 09.03.2005 Against the background of an exceptional market for rolled steel products and tubes, the Salzgitter Group recorded a significant boost in earnings in financial year 2004. Consolidated Group sales rose 23 % to EUR 5.9 billion (2003: ...
INGELHEIM, Germany,, February 28 (ots/PRNewswire) - - Tipranavir/r More Effective Than Lopinavir/r in Large-Scale Studies of Treatment-Experienced HIV-Positive Patients New data from multiple analyses presented last week at the 12th Conference on Retroviruses and Opportunistic Infections support the efficacy of the investigational non-peptidic protease ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 31.01.2005 Preliminary figures for Basler show record turnover and earnings for 2004 - Record turnover of Euro 52.3 million, +47% vis-à-vis 2003 - Record pre-tax earnings of Euro 5.1 million ...
Glasgow, Scotland, November 18 (ots/PRNewswire) - - RESIST-2 Data Demonstrate Efficacy in Treatment-Experienced Patient Population New tipranavir pivotal Phase III data show that a statistically significant higher percentage of treatment-experienced HIV-positive patients taking tipranavir therapy achieved treatment response versus those taking other ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. USU Software AG publishes nine-monthly figures Möglingen, 18 November 2004. - In Q3 2004, USU Software AG (ISIN DE000A0BVU28) achieved Group sales of TEUR 4,754 (PY: TEUR 4,776), which were ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Business results Activity in the German construction sector continues to decline. The latest figures published by the Federal Statistical Office for the building construction market show that ...
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for tipranavir. Simultaneously the documentation was submitted to the FDA. Tipranavir is a non-peptidic protease inhibitor (NPPI) for ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Wienerberger AG (Vienna Stock Exchange: WIE, Reuters: WBSV.VI, Bloomberg: WIE AV), the world's largest producer of bricks, has signed a contract to acquire "thebrickbusiness" (TBB), the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Changes on the Supervisory Board Möglingen, 21 September 2004. The Chairman of the Supervisory Board, Markus Kress, and the member of the Supervisory Board, Werner Preuschhof, today resigned from their Supervisory Board seats at USU Software AG ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Although a certain number of construction projects were brought forward due to the scheduled reduction in the subsidy for owner-occupied housing, incoming orders in the building ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Second quarter revenues rose by 19% to EUR 626.4 million. In addition to business developing favourably, especially in the case of potash and magnesium products, the first-time consolidation of ...
